Pharmaceuticals
Rising spending per animal draws more competitors into the expanding market
Cats and dogs are living longer, driving higher spending on medicines and treatments. (Photo by Soichiro Ono)
MAYUKO SUZUKI
November 13, 2026 05:06 JST
TOKYO — As pets in Japan live longer, demand for treatments targeting cancer and chronic conditions is climbing, prompting animal-health companies such as U.S.-based Zoetis to introduce new therapies in the country.
Zoetis, the world’s largest animal-health company, is preparing to roll out several treatments it views as potential blockbusters, betting that Japan’s aging pet population will sustain long-term growth in veterinary care spending.
The move reflects a broader shift in the Japanese market, where owners are increasingly willing to invest in advanced medical care for their companion animals. That trend is drawing a growing roster of domestic and international players eager to capture a share of the expanding field.
Also Read
- European Most-Wanted Cocaine Kingpin Allegedly Protected by Sierra Leone’s Elite
- Mercedes-Benz Suspends German Plant Investment, Evaluates Potential Closures
- Fed Drops Rate Vote from October 2027 Meeting in Strategic Calendar Overhaul
- Fatal Brooklyn Building Collapse Leaves Community Grieving and Demanding Accountability